BUZZ-Twist Bioscience rises as quarterly revenue beats estimates

Reuters11-18
BUZZ-Twist Bioscience rises as quarterly revenue beats estimates

** Synthetic biological products maker Twist Bioscience's TWST.O shares rise 13.8% to $41.99 premarket

** Co's fiscal Q4 rev of $84.7 mln beats analysts' est of $82.2 mln - LSEG

** Co reports fiscal Q4 loss of 59 cents/share, smaller than analysts' est of a loss of 71 cents/share - LSEG

** Co forecasts rev of $367 mln to $377 mln for fiscal year ending Sept 2025 vs est of $371.4 mln - LSEG

** TWST also forecasts Q1 FY25 rev of ~87 mln

** Nine of 12 brokerages rate the stock "buy" or higher, 2 "hold" and 1 "sell"; their median PT is $54 - LSEG

** As of last close, stock has risen 0.1% YTD

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment